Literature DB >> 27220481

Bone metastasis: the importance of the neighbourhood.

Peter I Croucher1,2,3, Michelle M McDonald1,2, T John Martin4,5.   

Abstract

During the past decade preclinical studies have defined many of the mechanisms used by tumours to hijack the skeleton and promote bone metastasis. This has led to the development and widespread clinical use of bone-targeted drugs to prevent skeletal-related events. This understanding has also identified a critical dependency between colonizing tumour cells and the cells of bone. This is particularly important when tumour cells first arrive in bone, adapt to their new microenvironment and enter a long-lived dormant state. In this Review, we discuss the role of different bone cell types in supporting disseminated tumour cell dormancy and reactivation, and highlight the new opportunities this provides for targeting the bone microenvironment to control dormancy and bone metastasis.

Entities:  

Mesh:

Year:  2016        PMID: 27220481     DOI: 10.1038/nrc.2016.44

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  217 in total

1.  Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches.

Authors:  S K Nilsson; H M Johnston; J A Coverdale
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

Review 2.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  Breast cancer cells interact with osteoblasts to support osteoclast formation.

Authors:  R J Thomas; T A Guise; J J Yin; J Elliott; N J Horwood; T J Martin; M T Gillespie
Journal:  Endocrinology       Date:  1999-10       Impact factor: 4.736

4.  Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.

Authors:  P I Croucher; C M Shipman; J Lippitt; M Perry; K Asosingh; A Hijzen; A C Brabbs; E J van Beek; I Holen; T M Skerry; C R Dunstan; G R Russell; B Van Camp; K Vanderkerken
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

5.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

6.  Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts.

Authors:  A Karadag; B O Oyajobi; J F Apperley; R G Russell; P I Croucher
Journal:  Br J Haematol       Date:  2000-02       Impact factor: 6.998

7.  Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.

Authors:  I Breitkreutz; M S Raab; S Vallet; T Hideshima; N Raje; C Mitsiades; D Chauhan; Y Okawa; N C Munshi; P G Richardson; K C Anderson
Journal:  Leukemia       Date:  2008-07-03       Impact factor: 11.528

8.  Zoledronic acid improves clinical outcomes in patients with bone metastatic hormone-naïve prostate cancer in a multicenter clinical trial.

Authors:  Takatsugu Okegawa; Masao Higaki; Tetsuo Matsumoto; Hiroshi Kase; Akihiro Murata; Kenjiro Noda; Haruhisa Noda; Hiroshi Asaoka; Masaya Oshi; Junzo Tomoishi; Hiroji Uchida; Eiji Higashihara; Kikuo Nutahara
Journal:  Anticancer Res       Date:  2014-08       Impact factor: 2.480

9.  Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.

Authors:  Younghun Jung; Jin Koo Kim; Yusuke Shiozawa; Jingcheng Wang; Anjali Mishra; Jeena Joseph; Janice E Berry; Samantha McGee; Eunsohl Lee; Hongli Sun; Jianhua Wang; Taocong Jin; Honglai Zhang; Jinlu Dai; Paul H Krebsbach; Evan T Keller; Kenneth J Pienta; Russell S Taichman
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more
  123 in total

Review 1.  Metastasis Organotropism: Redefining the Congenial Soil.

Authors:  Yang Gao; Igor Bado; Hai Wang; Weijie Zhang; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

2.  Metastatic dissemination patterns of different primary tumors to the spine and other bones.

Authors:  Julia S Onken; Lucius S Fekonja; Romy Wehowsky; Vanessa Hubertus; Peter Vajkoczy
Journal:  Clin Exp Metastasis       Date:  2019-08-16       Impact factor: 5.150

Review 3.  Novel approaches to target the microenvironment of bone metastasis.

Authors:  Lorenz C Hofbauer; Aline Bozec; Martina Rauner; Franz Jakob; Sven Perner; Klaus Pantel
Journal:  Nat Rev Clin Oncol       Date:  2021-04-19       Impact factor: 66.675

Review 4.  Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.

Authors:  Michelle M McDonald; Jesus Delgado-Calle
Journal:  Curr Osteoporos Rep       Date:  2017-12       Impact factor: 5.096

Review 5.  Haematopoietic stem cell activity and interactions with the niche.

Authors:  Sandra Pinho; Paul S Frenette
Journal:  Nat Rev Mol Cell Biol       Date:  2019-05       Impact factor: 94.444

6.  Tumor dormancy in bone.

Authors:  Vera Mayhew; Tolu Omokehinde; Rachelle W Johnson
Journal:  Cancer Rep (Hoboken)       Date:  2019-01-29

7.  Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study.

Authors:  Evangelos Terpos; Noopur Raje; Peter Croucher; Ramon Garcia-Sanz; Xavier Leleu; Waltraud Pasteiner; Yang Wang; Anthony Glennane; Jude Canon; Charlotte Pawlyn
Journal:  Blood Adv       Date:  2021-02-09

8.  Intrafibrillar, bone-mimetic collagen mineralization regulates breast cancer cell adhesion and migration.

Authors:  Siyoung Choi; Jens Friedrichs; Young Hye Song; Carsten Werner; Lara A Estroff; Claudia Fischbach
Journal:  Biomaterials       Date:  2018-05-07       Impact factor: 12.479

Review 9.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

10.  Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.

Authors:  Michael H Ross; Alison K Esser; Gregory C Fox; Anne H Schmieder; Xiaoxia Yang; Grace Hu; Dipanjan Pan; Xinming Su; Yalin Xu; Deborah V Novack; Thomas Walsh; Graham A Colditz; Gabriel H Lukaszewicz; Elizabeth Cordell; Joshua Novack; James A J Fitzpatrick; David L Waning; Khalid S Mohammad; Theresa A Guise; Gregory M Lanza; Katherine N Weilbaecher
Journal:  Cancer Res       Date:  2017-08-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.